| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2014PNAS..11116365K |
| P356 | DOI | 10.1073/PNAS.1411086111 |
| P932 | PMC publication ID | 4246298 |
| P698 | PubMed publication ID | 25368164 |
| P5875 | ResearchGate publication ID | 267814192 |
| P2093 | author name string | Yosef Shaul | |
| Julia Adler | |||
| Matan Shanzer | |||
| Nina Reuven | |||
| Rom Keshet | |||
| Zina Bryansker Kraitshtein | |||
| P2860 | cites work | Role for c-Abl tyrosine kinase in growth arrest response to DNA damage. | Q41183906 |
| Reactive oxygen species facilitate adipocyte differentiation by accelerating mitotic clonal expansion. | Q41818769 | ||
| The PPARgamma2 A/B-domain plays a gene-specific role in transactivation and cofactor recruitment | Q42289397 | ||
| Dynamic protein pathway activation mapping of adipose-derived stem cell differentiation implicates novel regulators of adipocyte differentiation | Q42595969 | ||
| Down-regulation of platelet-derived growth factor receptor expression during terminal differentiation of 3T3-L1 pre-adipocyte fibroblasts | Q42812177 | ||
| Interdomain communication regulating ligand binding by PPAR-gamma | Q42823872 | ||
| Requirement of caspase-mediated cleavage of c-Abl during stress-induced apoptosis | Q42833330 | ||
| Plasma adiponectin levels are markedly elevated in imatinib-treated chronic myeloid leukemia (CML) patients: a mechanism for improved insulin sensitivity in type 2 diabetic CML patients? | Q43064176 | ||
| Genotoxic damage of human adipose-tissue derived mesenchymal stem cells triggers their terminal differentiation. | Q43281360 | ||
| Increased levels of the Drosophila Abelson tyrosine kinase in nerves and muscles: subcellular localization and mutant phenotypes imply a role in cell-cell interactions | Q43626138 | ||
| The Pro12Ala PPARgamma2 variant determines metabolism at the gene-environment interface | Q46178580 | ||
| Long-term imatinib therapy promotes bone formation in CML patients | Q46278690 | ||
| Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation | Q46671380 | ||
| Suppression of PDGF-induced PI3 kinase activity by imatinib promotes adipogenesis and adiponectin secretion | Q62087952 | ||
| c-Abl stabilizes p73 by a phosphorylation-augmented interaction | Q73537085 | ||
| Abl expression in human fetal and adult tissues, tumours, and tumour microvessels | Q74016833 | ||
| c-Abl has high intrinsic tyrosine kinase activity that is stimulated by mutation of the Src homology 3 domain and by autophosphorylation at two distinct regulatory tyrosines | Q74241732 | ||
| Phosphorylation of DNA topoisomerase I by the c-Abl tyrosine kinase confers camptothecin sensitivity | Q24305397 | ||
| Yap1 phosphorylation by c-Abl is a critical step in selective activation of proapoptotic genes in response to DNA damage | Q24314457 | ||
| A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis | Q27860471 | ||
| Direct interaction of nerve growth factor receptor, TrkA, with non-receptor tyrosine kinase, c-Abl, through the activation loop | Q28138059 | ||
| c-Abl: activation and nuclear targets | Q28138395 | ||
| Interaction of c-Abl and p73alpha and their collaboration to induce apoptosis | Q28138604 | ||
| Identification of a ten-amino acid proline-rich SH3 binding site | Q28266446 | ||
| Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene | Q28512170 | ||
| An adipogenic cofactor bound by the differentiation domain of PPARgamma | Q28586511 | ||
| Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor | Q29547912 | ||
| Fat and beyond: the diverse biology of PPARgamma | Q29615416 | ||
| mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer | Q29617271 | ||
| PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance | Q29622888 | ||
| Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation | Q29871427 | ||
| Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors | Q33918083 | ||
| Src family kinase/abl inhibitor dasatinib suppresses proliferation and enhances differentiation of osteoblasts. | Q34067118 | ||
| The molecular control of adipogenesis, with special reference to lymphatic pathology | Q35051507 | ||
| Isoform-specific functions of c-abl: type I is necessary for differentiation, and type IV is inhibitory to apoptosis | Q36827735 | ||
| Identification of a peroxisome proliferator-responsive element upstream of the gene encoding rat peroxisomal enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase | Q37153866 | ||
| A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity | Q38331543 | ||
| Generation of megakaryocytes and platelets from preadipocyte cell line 3T3-L1, but not the parent cell line 3T3, in vitro | Q39637396 | ||
| PPARgamma knockdown by engineered transcription factors: exogenous PPARgamma2 but not PPARgamma1 reactivates adipogenesis | Q39753643 | ||
| Role of c-Abl in directing metabolic versus mitogenic effects in insulin receptor signaling. | Q40109546 | ||
| The nuclear receptor superfamily: a personal retrospect on the first two decades | Q40417646 | ||
| Transcriptional activity of peroxisome proliferator-activated receptor gamma is modulated by SUMO-1 modification | Q40559915 | ||
| Participation of ATM in insulin signalling through phosphorylation of eIF-4E-binding protein 1. | Q40833566 | ||
| Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma | Q41144553 | ||
| P433 | issue | 46 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | adipocyte | Q357519 |
| P304 | page(s) | 16365-16370 | |
| P577 | publication date | 2014-11-03 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | c-Abl tyrosine kinase promotes adipocyte differentiation by targeting PPAR-gamma 2. | |
| P478 | volume | 111 |
| Q64287734 | Inhibition of oncogenic Src induces FABP4-mediated lipolysis via PPARγ activation exerting cancer growth suppression |
| Q41965458 | Investigations on Binding Pattern of Kinase Inhibitors with PPARγ: Molecular Docking, Molecular Dynamic Simulations, and Free Energy Calculation Studies. |
| Q58692376 | KMUP-1, a GPCR Modulator, Attenuates Triglyceride Accumulation Involved MAPKs/Akt/PPARγ and PKA/PKG/HSL Signaling in 3T3-L1 Preadipocytes |
| Q49168585 | Over-expression of PPAR-γ2 gene enhances the adipogenic differentiation of hemangioma-derived mesenchymal stem cells in vitro and in vivo |
| Q91838742 | Peroxisome proliferator-activated receptor gamma as a theragnostic target for mesenchymal-type glioblastoma patients |
| Q54108748 | Semaphorin 6D reverse signaling controls macrophage lipid metabolism and anti-inflammatory polarization. |
| Q57462658 | The E3 ubiquitin ligase TRIM25 regulates adipocyte differentiation via proteasome-mediated degradation of PPARγ |
| Q42236165 | c-Abl forces YAP to switch sides |
| Q42058768 | c-Abl inhibition mitigates diet-induced obesity through improving insulin sensitivity of subcutaneous fat in mice |
Search more.